Alm Soravis Osataphan, MD

23 posts

Alm Soravis Osataphan, MD

Alm Soravis Osataphan, MD

@alm_o

GI oncologist focusing on cholangiocarcinoma and neuroendocrine tumors @BIDMChealth & @HarvardMed. Views are my own. #GIOncology #Cholangiocarcinoma #Metabolism

Boston,MA Katılım Ocak 2010
216 Takip Edilen113 Takipçiler
Sabitlenmiş Tweet
Alm Soravis Osataphan, MD
Alm Soravis Osataphan, MD@alm_o·
Just in from @NEJM - Our case report on the use of anti-insulin receptor antibodies as a novel strategy to tackle refractory hypoglycemia and malignant insulinoma! Immensely grateful to my mentors ME Patti and Ahmed Rattani and the ICU & endocrine team @BIDMChealth as well as the patient and their family for their unwavering trust and courage. 🌟 🎉 Read the full story at 🔗 nejm.org/doi/full/10.10… #GIoncology @OncoAlert
Alm Soravis Osataphan, MD tweet mediaAlm Soravis Osataphan, MD tweet mediaAlm Soravis Osataphan, MD tweet media
Boston, MA 🇺🇸 English
1
1
7
3.1K
Alm Soravis Osataphan, MD retweetledi
NEJM
NEJM@NEJM·
Neoadjuvant gemcitabine–oxaliplatin, lenvatinib, and anti–PD-1 antibody led to longer event-free survival than surgery alone in resectable high-risk intrahepatic cholangiocarcinoma, with mainly low-grade adverse events. Full phase 2–3 ZSAB-neoGOLP trial results: nejm.org/doi/full/10.10…
NEJM tweet media
English
0
20
68
10.1K
Alm Soravis Osataphan, MD retweetledi
Myriam Chalabi
Myriam Chalabi@MyriamChalabi·
Excited, happy and proud to share our @Nature publication on neoadjuvant ICB in pMMR colon cancer; #NICHE! We provide validation of previous clinical results, plus extensive and comprehensive analyses of Overdue tweetorial below❗️ nature.com/articles/s4158…
English
2
52
159
18.6K
Alm Soravis Osataphan, MD retweetledi
Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation@ConquerCancerFd·
Dr. Clifford Hudis, Executive Vice Chair of Conquer Cancer and CEO of @ASCO, on the importance of funding research for every cancer, from the common to the rare. Support rare cancer research at: brnw.ch/21wVGhM
Conquer Cancer, the ASCO Foundation tweet media
English
0
13
30
7K
Alm Soravis Osataphan, MD
Alm Soravis Osataphan, MD@alm_o·
September is Rare Cancer Awareness Month - including cholangiocarcinoma, a disease near and dear to my heart. 💚 Please join me and @ConquerCancerFd in supporting research to bring hope to patients & families facing this devastating diagnosis. tinyurl.com/4ewfd68s
Alm Soravis Osataphan, MD tweet media
English
0
0
2
137
Alm Soravis Osataphan, MD
Alm Soravis Osataphan, MD@alm_o·
Thank you @Erman_Akkus for highlighting our MTAP study. Notably, we did not find association between OS & CDKN2A/B loss when MTAP was intact – raising an importance ❓ if CDKN2A/B mutations are bystanders and the biological roles of these 3 proteins in CCA progression @curecc
Erman Akkus@Erman_Akkus

🧬MTAP loss in cholangiocarcinoma @JCOPO_ASCO ➡️Frequency: 16% 🚨Worse OS HR: 3.95 [1.43 to 10.9]; P = .008 ❗️An actionable target 👉ascopubs.org/doi/10.1200/PO… #cancer #oncology #biliary #MedX @OncoAlert @PrecisionBTCnet @curecc

English
1
6
13
1.7K
Alm Soravis Osataphan, MD retweetledi
Deepa Rangachari, MD, FASCO
Deepa Rangachari, MD, FASCO@DeepaRangachari·
Immensely proud of and grateful for this village! We gathered to celebrate intelligence, integrity, curiosity, and compassion. Congratulations to our graduating ⁦@BIDMC_HOFellows⁩ and thank you to our ⁦⁦BIDMC Heme/Onc family. May your stars shine bright always! ⁦⁦
Deepa Rangachari, MD, FASCO tweet media
English
0
5
16
1.3K
Alm Soravis Osataphan, MD retweetledi
Shruti Patel, MD
Shruti Patel, MD@ShrutiPatelMD·
“Not everything that counts can be counted. Not everything that can be counted, counts.” -@marklewismd In oncology, metrics matter. But meaning or time or values? You can’t quantify those. That’s why shared decision-making isn’t just a buzzword; it’s the ENTIRE point. #ASCO25
English
2
30
107
13.5K
Chanmi Lee
Chanmi Lee@ChanmiLee·
A sincere congratulations Alm!! So well-deserved!!!! 🥳🥳🎉🎉🎉
Alm Soravis Osataphan, MD@alm_o

Thank you @melinda_bachini and @curecc for supporting my @ASCO YIA application and @ConquerCancerFd for funding our study to advance the understanding of cholangiocarcinoma tumor microenvironment. Incredibly grateful for the mentorship from the BI team ML peters, @ioavlachos and the fellowship team, @DeepaRangachari and @rushadpatell. Cant think of a better occassion to celebrate with the kindest oncologists I know 💚💚💚@PhuwanatS @brian_russell39 @maxwellRlloyd @BIDMC_HOFellows @BIDMC_CancerCtr #ASCO25 #ConquerCancer

English
1
0
2
210
Alm Soravis Osataphan, MD
Alm Soravis Osataphan, MD@alm_o·
Thank you @melinda_bachini and @curecc for supporting my @ASCO YIA application and @ConquerCancerFd for funding our study to advance the understanding of cholangiocarcinoma tumor microenvironment. Incredibly grateful for the mentorship from the BI team ML peters, @ioavlachos and the fellowship team, @DeepaRangachari and @rushadpatell. Cant think of a better occassion to celebrate with the kindest oncologists I know 💚💚💚@PhuwanatS @brian_russell39 @maxwellRlloyd @BIDMC_HOFellows @BIDMC_CancerCtr #ASCO25 #ConquerCancer
Alm Soravis Osataphan, MD tweet mediaAlm Soravis Osataphan, MD tweet mediaAlm Soravis Osataphan, MD tweet mediaAlm Soravis Osataphan, MD tweet media
English
2
5
19
1.2K
Alm Soravis Osataphan, MD retweetledi
Deepa Rangachari, MD, FASCO
Deepa Rangachari, MD, FASCO@DeepaRangachari·
@BIDMC_CancerCtr and @BIDMC_HOFellows are elated and proud to celebrate our very own senior fellow Dr. @alm_o for this incredibly well deserved recognition— may your curiosity and innovation continue to soar and lead us to new heights! @rushadpatell #ASCO25
Conquer Cancer, the ASCO Foundation@ConquerCancerFd

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO

English
0
6
16
1.7K
BIDMC Hematology/Oncology Fellowship
BIDMC Hematology/Oncology Fellowship@BIDMC_HOFellows·
Welcome to the BIDMC family to this outstanding group of incoming fellows in Heme/Onc, Hematology, and combined Heme/Onc & Hospice/Palliative Care!! Congratulations and happy #MatchDay to all!
Deepa Rangachari, MD, FASCO@DeepaRangachari

We are beyond elated to welcome the newest members of our BIDMC family: Heme/Onc, Heme-Focused, and the inaugural Heme-Onc/Hospice & Palliative Medicine fellows!! We look forward to with partnering with and mentoring you! @BIDMC_HOFellows @BIDMC_Medicine @BIDThoracicOnc

English
4
2
40
4.2K

Keşfet

@Nature @BrunoBockorny @pdwhooley @JessZerilloMD @MLBTPeters @BIDMC_CancerCtr @PornladaL @curecc